Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This clinical study will assess the safety, reactogenicity and immunogenicity of mRNA-1653, a combined human metapneumovirus and human parainfluenza virus type 3 vaccine in healthy adults.
Epistemonikos ID: 9a554d9afb1ffb04de740ce1ddb3be35a6cb87a5
First added on: Mar 23, 2020